- Home
- CVR vs PIRS Comparison
CVR vs PIRS Comparison
Compare CVR & PIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- PIRS
- Stock Information
- Founded
- CVR 1920
- PIRS 2001
- Country
- CVR United States
- PIRS United States
- Employees
- CVR N/A
- PIRS N/A
- Industry
- CVR Industrial Machinery/Components
- PIRS Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- PIRS Health Care
- Exchange
- CVR Nasdaq
- PIRS Nasdaq
- Market Cap
- CVR 20.0M
- PIRS 22.4M
- IPO Year
- CVR N/A
- PIRS N/A
- Fundamental
- Price
- CVR $18.25
- PIRS $15.93
- Analyst Decision
- CVR
- PIRS
- Analyst Count
- CVR 0
- PIRS 0
- Target Price
- CVR N/A
- PIRS N/A
- AVG Volume (30 Days)
- CVR 3.6K
- PIRS 37.6K
- Earning Date
- CVR 11-12-2024
- PIRS 11-13-2024
- Dividend Yield
- CVR 2.22%
- PIRS N/A
- EPS Growth
- CVR N/A
- PIRS N/A
- EPS
- CVR N/A
- PIRS N/A
- Revenue
- CVR $29,663,473.00
- PIRS $1,352,000.00
- Revenue This Year
- CVR N/A
- PIRS N/A
- Revenue Next Year
- CVR N/A
- PIRS N/A
- P/E Ratio
- CVR N/A
- PIRS N/A
- Revenue Growth
- CVR N/A
- PIRS N/A
- 52 Week Low
- CVR $13.81
- PIRS $6.20
- 52 Week High
- CVR $22.27
- PIRS $22.32
- Technical
- Relative Strength Index (RSI)
- CVR 44.06
- PIRS 43.29
- Support Level
- CVR $17.00
- PIRS $15.15
- Resistance Level
- CVR $20.64
- PIRS $16.97
- Average True Range (ATR)
- CVR 0.77
- PIRS 0.72
- MACD
- CVR -0.25
- PIRS -0.08
- Stochastic Oscillator
- CVR 23.72
- PIRS 30.75
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.
About PIRS Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.